HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SLQT

SelectQuote, Inc. (NYSE)

Financial Services — Insurance Brokers

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution and engagement platform that sells insurance policies and healthcare services in the United States. The company operates through three segments: Senior, Healthcare Services, and Life. It offers medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance-related products, as well as engages in lead generation business; term life, final expense, and other ancillary products; non-commercial auto and home, property, and casualty insurance products. The company also provides SelectRx, a patient-centered pharmacy; Healthcare Select, which uses data from personal health risk and lifestyle assessment; HomeTM (PCPH), an accredited pharmacy; SelectPatient Management (SPM), a platform that helps patients navigate their chronic conditions and manage them using a treatment plan; and individual automobile and homeowners' insurance. SelectQuote, Inc. was incorporated in 1999 and is headquartered in Overland Park, Kansas.

None 4 analysts
$0.72
$-0.02 (-3.13%)
Target: $3.06 (325.3%)
Sign in to add SLQT to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$152.91M
P/E Ratio (TTM)-
Forward P/E4.56
EPS (TTM)$-0.01
Dividend Yield-
Profit Margin5.60%
Revenue Growth5.60%
ROE15.05%
Debt/Equity61.02
Recommendation None
Analyst Target$3.06
Analysts4
Indexes NYSE

Technical Indicators

RSI (14)47.0
Beta1.61
SMA 20-
SMA 40-
52-Week High$2.77
52-Week Low$0.56
50-Day Avg$0.97
200-Day Avg$1.26
Avg Volume$2.15M
Volume530.1K

Performance Analysis

NEUTRAL

SLQT presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($0.56), which could present a value opportunity.
~ RSI at 47.0 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 5.6% year-over-year.
~ Wall Street consensus is "none" from 4 analysts.
+ Average analyst target of $3.06 implies 325.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:31 UTC

Back to Screener Export Report